RESULTS	Mortality rates were similar in both groups ( G-CSF group , 70 % ; placebo group , 87 % ; risk ratio , 0.81 ; 95 % confidence interval , 0.61-1 .06 ; P = .2 ) , including among patients with confirmed melioidosis ( 83 % vs. 96 % ; P = .3 ) .\